Geriatric drug therapy: Neglecting the inevitable majority

Ageing Research Reviews

Volumn 9, Issue 4, 2010, Pages 384-398

  Stegemann, Sven ^a   Ecker, Felix ^b   Maio, Mario ^c   Kraahs, Peter ^d   Wohlfart, Rainer ^e   Breitkreutz, Joerg ^f   Zimmer, Andreas ^g   Bar Shalom, Daniel ^h   Hettrich, Patrick ⁱ   Broegmann, Bianca ^j  

^a CAPSUGEL   (France)

^b FULDA UNIVERSITY OF APPLIED SCIENCES   (Germany)

^c Merck Serono GmbH   (Germany)

^d Losan Pharma GmbH   (Germany)

^e Kneipp Werke   (Germany)

^f HEINRICH HEINE UNIVERSITY   (Germany)

^g UNIVERSITY OF GRAZ   (Austria)

^h UNIVERSITY OF COPENHAGEN   (Denmark)

ⁱ Mepha Pharma AG   (Switzerland)

^j Evonik Rohm GmbH   (Germany)

more..

Author keywords

Age related; Changes; Elderly; Geriatric medicine; Medication management; Multidisciplinary science

Indexed keywords

BENZODIAZEPINE DERIVATIVE; CLOMETHIAZOLE; FEXOFENADINE; KETOPROFEN; LIDOCAINE; PHENAZONE; RIFAMPICIN; SOTALOL;

AGING; COGNITION; DRUG ABSORPTION; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG HALF LIFE; DRUG METABOLISM; HEALTH CARE COST; HEALTH CARE INDUSTRY; HEALTH CARE QUALITY; HEALTH CARE SYSTEM; HUMAN; LIFE EXPECTANCY; LONG TERM CARE; PATIENT COMPLIANCE; PRESCRIPTION; REVIEW; RHEUMATOID ARTHRITIS; SWALLOWING; VISION; VISUAL IMPAIRMENT;

AGED; AGED, 80 AND OVER; AGING; AUSTRIA; BELGIUM; CHRONIC DISEASE; CLINICAL PHARMACY INFORMATION SYSTEMS; DENMARK; DRUG ADMINISTRATION ROUTES; DRUG TOXICITY; GERMANY; HEALTH CARE COSTS; HEALTH SERVICES FOR THE AGED; HUMANS; MEDICATION ADHERENCE; PATIENT CARE TEAM; POLYPHARMACY; POPULATION DYNAMICS; SWITZERLAND;

EID: 78650676931     PISSN: 15681637     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.arr.2010.04.005     Document Type: Review

References (126)

1. Ahmed N., Mandel R., Fain M.J. Frailty: an emerging geriatric syndrome. Am. J. Med. 2007, 120(9):748-753.
2. Andersen O., Zweidorff O.K., Hjelde T., Rodland E.A. Problems when swallowing tablets. A questionnaire study from general practice. Tidsskr Nor Laegeforen 1995, 115(8):947-949.
3. Atkin P.A., Finnegan T.P., Ogle S.J., Shenfield G.M. Functional ability of patients to manage medication packaging: a survey of geriatric inpatients. Age and Ageing 1994, 23:113-116.
4. Balkrishnan R. Predictors of medication adherence in the elderly. Clin. Ther. 1998, 20:764-771.
5. Ball K., Berch D.B., Helmers K.F., Jobe J.B., Leveck M.D., Marsiske M., Morris J.N., Rebok G.W., Smith D.M., Tennstedt S.L., Unverzagt F.W., Willis S.L. Effects of cognitive training interventions with older adults: a randomized controlled trial. JAMA 2002, 288(18):2271-2281.
6. Bassill N., Grossberg G.T. Novel regimens and delivery systems in the pharmacological treatment of Alzheimer's disease. CNS Drugs 2009, 23(4):293-307.
7. Becker M.L., Visser L.E., van Gelder T., Hofman A., Stricker B.H.Ch. Increasing exposure to drug-drug interactions between 1992 and 2005 in people aged ≥55 years. Drugs Aging 2008, 25(2):145-152.
8. Beckman A.G.K., Parker M.G., Thorslund M. Can elderly people take their medicines?. Patient Education and Counseling 2005, 59:186-191.
9. Beckmann Gyllenstrand, A., 2007. Medication management and patient compliance in old age. Ph.D. Thesis. Karolinska Insitutet, Department of Neurobiology, Caring Sciences and Society, Stockholm, Sweden.
10. Beers M.H. Explicit criteria for determining potentially inappropriate medication use by the elderly. Arch. Intern. Med. 1997, 157(14):1436-1531.
11. Benet L.Z., Hoener B.-A. Changes in plasma protein binding have little clinical relevance. Clin. Pharmacol. Ther. 2002, 71(3):115-121.
12. Biron C., Licznar P., Hansel S., Schved J.F. Oral anticoagulant drugs: do not cut tablets in quarters. Thromb. Haemost. 1999, 82:1201.
13. Björkman I.K., Fastbom J., Schmidt I.K., Bernsten C.B. Drug-drug interactions in the elderly. Ann. Pharmacother. 2002, 36:1675-1681.
14. Boobis A., Watelet J.-B., Whomsley R., Strolin Benedetti M., Demoly P., Tipton K. Drug interactions. Drug Metab. Rev. 2009, 41(3):486-527.
15. Brodde O.-E., Leineweber K. Autonomic receptor systems in the failing and aging human heart: similarities and differences. Eur. J. Pharmacol. 2004, 500:167-176.
16. Burkhardt H., Gladisch L. Pharmakotherapie des älteren Menschen aus klinischer Sicht. Internist 2003, 44:959-967. (also see: http://www.base-berlin.mpg.de).
17. Bushardt R.L., Massey E.B., Simpson T.W., Ariail J.C., Simpson K.N. Polypharmacy: misleading, but manageable. Clin. Interven. Aging 2008, 3(2):383-389.
18. Butler M.J., Begg E.J. Free drug metabolic clearance in elderly people. Clin. Pharmacokinet. 2008, 47(5):297-321.
19. Cannon K.T., Choi M.M., Zuniga M.A. Potentially inappropriate medication use in elderly patients receiving home health care: a retrospective data analysis. Am. J. Geriat. Pharmacother. 2006, 4(2):134-143.
20. Carmeli E., Patish H., Coleman R. The aging hand. J. Gerontol. Med. Sci. 2003, 58A(2):146-152.
21. Carnaby-Mann G., Crary M. Pill swallowing by adults with dysphargia. Arch. Otopharyngol. Head Neck Surg. 2005, 131:970-975.
22. Chasteen A.L., Park D.C., Schwarz N. Implementation intentions and facilitation of prospective memory. Psychol. Sci. 2001, 12(6):457-461.
23. Comas-Herrera, A., Costa-Font, J., Gori, C., di Maio, A., Patxot, C., Pickard, L., Pozzi, A., Rothgang, H., Wittenberg, R., 2003. European study of long-term care expenditure. European Commission VS/2001/0272.
24. Conn V.S., Hafdahl A.R., Cooper P.S., Ruppar T.M., Mehr D.R., Russell C.L. Interventions to improve medication adherence among older adults: meta-analysis of adherence outcomes among randomized controlled trials. Gerontologist 2009, 49(4):447-462.
25. Cook T.J., Edwards S., Gyemah C., Shah M., Shah I., Fox T. Variability in tablet fragment weights when splitting unscored cyclobenzaprine 10mg tablets. J. Am. Pharm. Assoc. 2004, 44(5):583-586.
26. Cusack B.J. Pharmacokinetics in older persons. Am. J. Geriat. Pharmacother. 2004, 2(4):274-302.
27. Delafuente J.C. Understanding and preventing drug interactions in elderly patients. Crit. Rev. Oncol. Hematol. 2003, 48:133-143.
28. Einstein G.O., Smith R.E., McDaniel M.A., Shaw P. Aging and prospective memory: the influence of increased task demands at encoding and retrieval. Psychol. Aging 1997, 12(3):479-488.
29. Ekberg O., Feinberg M.J. Altered swallowing function in elderly patients without dysphgia: radiologic findings in 56 cases. AJR 1991, 156:1181-1184.
30. Ernst F.R., Grizzle A.J. Drug-related morbidity and mortality: up-dating the cost-of-illness model. J. Am. Pharm. Assoc. 2001, 41(2):192-199.
31. Eskildsen M., Price T. Nursing home care in the USA. Geriatr. Gerontol. Int. 2009, 9:1-6.
32. European Study of Long-term Care Expenditure, 2003. PSSRU Discussion Paper 1840. London School of Economics, London.
33. Evans J.R., Fletcher A.E., Wormald R.P.L., Siu-Woon Ng E., Stirling S., Smeeth L., Breeze E., Bulpitt C.J., Nunes M., Jones D., Tulloch A. Prevalence of visual impairment in people aged 75 years and older in Britain: results from the MRC trial of assessment and management of older people in the community. Br. J. Ophthalmol. 2002, 86:795-800.
34. Fu A.Z., Jiang J.Z., Reeves J.H., Fincham J.E., Liu G.G., Perri M. Potentially inappropriate medication use and healthcare expenditures in the US community-dwelling elderly. Med. Care 2007, 45(5):472-476.
35. George J., Elliott R.A., Stewart D.C. A systematic review of interventions to improve medication taking in elderly patients prescribed multiple medications. Drugs Aging 2008, 25(4):307-324.
36. Gidal B.E. Drug absorption in the elderly: biopharmaceutical considerations for the antiepileptic drugs. Epilepsy Res. 2006, 68S:S65-S69.
37. Gillespie U., Alassaad A., Henrohn D., Garmo H., Hammarlund-Udesaes M., Toss H., Kettis-Lindblad A., Melhus H., Morlin C. A comprehensive pharmacist intervention to reduce morbidity in patients 80 years or older. Arch. Med. Intern. 2009, 169(9):894-900.
38. Gleeson T., Iverson M.D., Avron J., Brookhart A.M., Katz J.N., Losina E., May F., Patrick A.R., Shrank W.H., Solomon D.H. Interventions to improve adherence and persistence with osteoporosis medications: a systematic literature review. Osteopor. Int. 2009, 20:2127-2134.
39. Glisky E.L. Changes in cognitive function in human aging. Brain Aging Models, Methods, Mechanisms 2007, CRC Press.
40. Gollwitzer P.M. Implementation intentions. Am. Psychologist 1999, 54(7):493-503.
41. Gurwitz J.H., Field T.S., Harrold L.R., Rothschild J., Debellis K., Seger A.C., Cadoret C., Fish L.S., Garber L., Kelleher M., Bates D.W. Incidence and preventability of adverse drug events among older persons in the ambulatory setting. JAMA 2003, 289(9):1107-1116.
42. Gurwitz J.H., Field T.S., Judge J., Rochon P., Harrold L.R., Cadoret C., Lee M., White K., LaPrino J., Erramuspe-Mainard J., DeFlorio M., Gavendo L., Auger J., Bates B.W. The incidence of adverse drug events in two large academic long-term-care facilities. Am. J. Med. 2005, 118(3):251-258.
43. Hajjar E.R., Cafiero A.C., Hanlon J.T. Polypharmacy in elderly patients. Am. J. Geriat. Pharmacother. 2007, 5(4):345-351.
44. Hamman M.A., Bruce M.A., Haehner-Daniels B.D., Hall S.D. The effect of rifampin administration on the disposition of fexofenadine. Clin. Pharmacol. Ther. 2001, 69(3):114-121.
45. Hanlon J.T., Schmader K.E., Koronkowski M.J., Weinberger M., Landsman P.B., Samsa G.P., Lewis I.K. Adverse drug events in high risk older outpatients. J. Am. Geriatr. Soc. 1997, 157:2089-2096.
46. Hayes T.L., Cobbinah K., Dishongh T., Kaye J.A., Kimmel J., Labhard M., Leen T., Lundell J., Ozertem U., Pavel M., Philipose M., Rhodes K., Vurgun S. A study of medication-taking and unobtrusive, intelligent reminding. Telemed. e-Health 2009, 15(8):770-776.
47. Herrlinger C., Klotz U. Drug metabolism and drug interactions in the elderly. Best Pract. Res. Clin. Gastroenterol. 2001, 15(6):897-918.
48. Hersberger, J., 1997. Differenzierbarkeit und Präferenz von Kapselfarben bei älteren Menschen. Lizentiatsarbeit Universität Basel, Institute für Psychologie.
49. Hilmer S.N., McLachlan A.J., Le Couteur D.G. Clinical pharmacology in the geriatric patient. Fundam. Clin. Pharmacol. 2007, 21:217-230.
50. Hind J.A., Nicosia M.A., Roecker E.B., Carnes M.L., Robbins J. Comparison of effortful and noneffortful swallows in healthy middle-aged and older adults. Arch. Phys. Med. Rehabil. 2001, 82:1661-1665.
51. Hirdes J.P., Ljunggren G., Morris J.N., Frijters D.H.M., Finne Soveri H., Gray L., Björkgren M., Gilgen R. Reliability of the interRAI suite of assessment instruments: a 12-country study of an integrated health information system. BMC Health Services Res. 2008, 8:277-288.
52. Hoyer W.J. Positive contributions of the elderly to society: a multidisciplinary perspective. Aust. J. Ageing 2008, 17(s1):39-41.
53. Hughes C.M. Medication non-adherence in the elderly. How big is the problem. Drugs Aging 2004, 21(12):793-811.
54. Hurwitz A., Ruhl C.E., Kimler B.F., Topp E.M., Mayo M.S. Gastric function in the elderly: effects on absorption of Ketoconazole. J. Clin. Pharmacol. 2003, 43:996-1002.
55. Hutchison L.C., Jones S.K., West D.S., Wei J.Y. Assessment of medication management by community-living elderly persons with two standardized assessment tools: a cross-sectional study. Am. J. Geriatr. Pharmacother. 2006, 4(2):144-153.
56. Jefferys D., Gennery B.A., Manos S., Baxter G., Page C. Pharma 2020 Virtual R&D. Which Pass will You Take? 2008, PriceWaterhouseCoopers.
57. Johnson J.A., Bootman J.L. Drug-related morbidity and mortality and the economic impact of pharmaceutical care. Am. J. Health Syst. Pharm. 1997, 54:554-558.
58. Juurlink D.N., Mamdani M., Kopp A., Laupacis A., Redelmaier D.A. Drug-drug interactions among elderly patients hospitalized for drug toxicity. JAMA 2003, 289(13):1652-1658.
59. Katz S., Downs T.D., Cash H.R., Grotz R.C. Progress in the development of the index of ADL. Gerontologist 1970, 10:20-30.
60. Katz M., Kripalani S., Weiss B.D. Use of pictoral aids in medication instructions: a review of the literature. Am. J. Health Syst. Pharm. 2006, 63:2391-2397.
61. Keram S., Williams M.E. Quantifying the ease or difficulty older persons experience in opening medication containers. J. Am. Geriatr. Soc. 1988, 36(3):198-201.
62. Kinirons M.T., O'Mahony M.S. Drug metabolism and aging. Br. J. Clin. Pharmacol. 2004, 57(5):540-544.
63. Klaver C.W., Wolfs R.C.W., Vingerling J.R., Hofman A., de Jong P.T.V.M. Age-specific prevalence and causes of blindness and visual impairment in an older population. Arch. Ophatalmol. 1998, 116:653-658.
64. Klotz U. Pharmacokinetics and drug metabolism in the elderly. Drug Metab. Rev. 2009, 41(2):67-76.
65. Lang F.R., Rieckmann N., Baltes M.M. Adapting to aging losses: do resources facilitate strategies of selection, compensation, and optimization in everyday functioning?. J. Gerontol. Psychol. Sci. 2002, 57B(6):P501-509.
66. Le Couteur D.G., McLean A.J. The aging liver. Drug clearance and an oxygen diffusion barrier hypothesis. Clin. Pharmacokinet. 1998, 34:359-373.
67. Lindenberger U., Ghisletta P. Cognitive and sensory declines in old age: gauging the evidence for a common cause. Psychol. Aging 2009, 24(1):1-16.
68. Liu L.L., Park D.C. Aging and medical adherence: the use of automatic processes to achieve effortful things. Psychol. Ageing 2004, 19(2):318-325.
69. Martin M., Park D.C. The Martin and Park environmental demands (MPED) questionnaire: psycholetric properties of a brief instrument to measure self-reported environmental demands. Aging Clin. Exp. Res. 2003, 15(1):77-82.
70. McDaniel M.A., Einstein G.O. Strategic and automatic processes in prospective memory retrieval: a multiprocess framework. Appl. Cogn. Psychol. 2000, 14:S127-S144.
71. McLean A.J., Le Couteur D.G. Aging biology and geriatric clinical pharmacology. Pharmacol. Rev. 2004, 56:163-184.
72. Meara E., White C., Cutler D.M. Trends in medical spending by age, 1963-2000. Health Affairs 2004, 23(4):176-183.
73. Melk A., Halloran P.F. Cell senescence and its implications for nephrology. J. Am. Soc. Nephrol. 2001, 12:385-393.
74. Miller S.W. Evaluating medication regimens in the elderly. Consultant Pharmacist 2008, 23(7):538-547.
75. Moisan J., Gaudet M., Grégpoire J.-P., Bouchard R. Non-compliance with drug treatment and reading difficulties with regard to prescription labeling among seniors. Gerontology 2002, 48(1):44-51.
76. Morris J.N., Fries B.E., Steel K., Ikegami N., Bernabei R., Carpenter G.I., Gilgen R., Hirdes J.P., Topinkova E. Comprehensive clinical assessment in community setting: applicability of the MDS-HC. J. Am. Geriatr. Soc. 1997, 45:1017-1024.
77. Morrow D.G., Weiner M., Young J., Steinley D., Deer M., Murray M.D. Improving medication knowledge among older adults with heart failure: a patient-centered approach to instruction design. Gerontologist 2005, 45(4):545-552.
78. Morrow D., Leirer V., Altier P. List formats improve medication instructions for older adults. Educ. Gerontol. 1995, 21(2):151-166.
79. Moscovitch M. Memory and working with memory: evaluation of a component process model and comparisons with other models. Memory Systems 1994, The MIT Press, Cambridge, MA. D.L. Schacter, E. Tulving (Eds.).
80. Muhlberg W., Platt D. Age-related changes of the kidneys: pharmacological implications. Gerontology 1999, 45:243-253.
81. Murray M.D., Young J., Hoke S., Tu W., Weiner M., Morrow D., Stroupe K.T., Wu J., Clark D., Smith F., Gradu-Pizlo I., Weinberger M., Brater D.C. Pharmacist intervention to improve medication adherence in heart failure. Ann. Intern. Med. 2007, 146:714-725.
82. Murray M.D., Morrow D., Weiner M., Clark D.O., Tu W., Deer M.M., Brater D.C., Weinberger M. A conceptual framework to study adherence in older adults. Am. J. Geriatr. Pharmacother. 2004, 2(1):36-43.
83. Nardi R., Scanelli G., Borioni D., Grandi M., Sacchetti C., Parenti M., Fiorino S., Iori I., Di Donato C., Agostinelli P., Cipollini F., Pelliccia G., Centurioni R., Pontoriero L. The assessment of complexity in internal medicine patients. The FAMedicomplex Study. Eur. J. Intern. Med. 2007, 18:283-287.
84. Naughton C., Bennett K., Feely J. Prevalence of chronic disease in the elderly based on a national pharmacy claims data base. Age Aging 2006, 35(6):633-636.
85. Nilsson H., Ekberg O., Olsson R., Hindfelt B. Quantitative aspects of swallowing in an elderly nondysphagic population. Dysphagia 1996, 11:180-184.
86. Nobili A., Pasina L., Tettamanti M., Lucca U., Riva E., Garzona I., Monesi L., Cucchiani R., Bortolotti A., Fortino I., Merlino L., Walter Locatelli G., Giuliani G. Potentially severe drug interactions in elderly outpatients: results of an observational study of an administrative prescription database. J. Clin. Pharm. Ther. 2009, 34:377-386.
87. Nöthen, M., Böhm, K., 2009. Costs of illness. Federal Health Reporting. Booklet 48, Robert Koch Institute (). http://www.rki.de/.
88. Orr W.C., Chen C.L. Aging and neural control of the GI tract IV. Clinical and physiological aspects of gastrointestinal motility and aging. Am. J. Physiol. Gastrointest. Liver Physiol. 2002, 283:G1226-G1231.
89. Overgaard A.B.A., Hojsted J., Hansen R., Moller-Sonnergaard J., Christrup L.L. Patients evaluation of shape, size and colour of solid dosage forms. Pharmacy World Sci. 2001, 23(5):185-188.
90. Palo J.D., Murphy J. Pharma 2020 Marketing the Future. Which Pass will You Take? 2009, PriceWaterhouseCoopers.
91. Park D.C., Gutchess A.H., Meade M.L., Stine-Morrow E.A.L. Improving cognitive function in older adults: nontraditional approaches. J. Gerontol. 2007, 62B(Special Issue I):45-52.
92. Park D.C., Hedden T. Working memory and aging. Perspectives on human memory and cognitive aging: essays in honor of Fergu Craik by M. Naveh-Benjamin, M. Moscovitch and H.L. Roediger 2001, Psychology Press, East Sussex, England.
93. Park D.C., Morrell R.W., Frieske D., Kincaid D. Medication adherence behaviors in older adults: effects of external cognitive support. Psychol. Aging 1992, 7(2):252-256.
94. Park D.C., Hertzog C., Leventhal H., Morrell R.W., Leventhal E., Birchmore D., Martin M., Bennett J. Medication adherence in rheumatoid arthritis patients: older is wiser. J. Am. Geriat. Soc. 1999, 47:172-183.
95. Peterson J.F., Kuperman G.J., Shek C., Patel M., Avorn J., Bates D.W. Guided prescription of phsychtropic medications for geriatric inpatients. Arch. Intern. Med. 2005, 165:802-807.
96. Phillips K.A., Van Bebber S.L. Measuring the value of pharmacogenomics. Nat. Rev. Drug Discov. 2005, 4:500-511.
97. Quinzler R., Gasse C., Schneider A., Kaufmann-Kolle P., Szecsenyi J., Haefeli W.E. The frequency of inappropriate tablet splitting in primary care. Eur. J. Clin. Pharmacol. 2006, 62:1065-1073.
98. Rodenhuis N., De Smet P.A.G.M., Barends D.M. The rational of scored tablets as dosage form. Eur. J. Pharm. Sci. 2004, 21:305-308.
99. Ruscin J.M., Semla T.P. Assessment of medication management skills in older outpatients. Ann. Pharmacother. 1996, 30:1083-1088.
100. World Health Organization. Adherence to Long-term Therapies: Evidence for Action 2003, WHO, Geneva. E. Sabaté (Ed.).
101. Scherder E., Dekker W., Eggermont L. Higher-level hand motoric functions in aging and (preclinical) dementia: its relationship with (instrumental) activities of daily life-a mini-review. Gerontology 2008, 54:333-341.
102. Schmucker D.L. Liver function and phase I drug metabolism in the elderly. Drugs Aging 2001, 18(11):837-851.
103. Sheth N., Diner W.C. Swallowing problems in the elderly. Dysphagia 1988, 2:209-215.
104. Shrank W., Avron J., Rolon C., Shekelle P. Effect of content and format of prescription drug labels on readability, understanding and medication use: a systematic review. Ann. Pharmacother. 2007, 41(5):783-801.
105. Smith J., Gerstorf D. Ageing differently: potential and limits. Ageing and Diversity: Multiple Pathways and Cultural Migrations 2004, 13-28. Policy Press, Bristol, England. S.O. Daatland, S. Biggs (Eds.).
106. Sotaniemi E.A., Arranto A.J., Pelkonen O., Pasanen M. Age and cytochrome P450-linked drug metabolism in humans: an analysis of 226 subjects with equal histopathologic conditions. Clin. Pharmacol. Ther. 1997, 61:331-339.
107. Stegemann S. Colored capsules-a contribution to drug safety. Pharm. Ind. 2005, 67(9):1088-1095.
108. Swanlund S.L. Successful cardiovascular medication management processes as perceived by community-dwelling adults over age 74. Appl. Nurs. Res. 2010, 23(1):22-29.
109. Tam-McDervitt J. Polypharmacy, aging, and cancer. Oncology 2008, 22(9):1052-1055.
110. Tulner L.R., Frankfort S.V., Gijsen G.J.P.T., van Campen J.P.C.M., Koks C.H.W., Beijnen J.H. Drug-drug interactions in a geriatric outpatient cohort-prevalence and relevance. Drugs Aging 2008, 25(4):343-355.
111. Turnheim K. Drug dosage in elderly: is it rational. Drug Aging 1998, 13:357-379.
112. Turnheim K. Drug therapy in the elderly. Exp. Gerontol. 2004, 39:1731-1738.
113. Turnheim K. Pharmacokinetic dosage guidelines for elderly subjects. Exp. Opin. Drug Metab. Toxicol. 2005, 1(1):33-48.
114. Van Santen E., Barends D.M., Frijlink H.W. Breaking of scored tablets: a review. EJPB 2001, 53:139-145.
115. Vik S.A., Maxwell C.J., Hogan D.B. Measurement, correlates and health outcomes of medication adherence among seniors. Ann. Pharmacother. 2004, 38:303-312.
116. Vik S.A., Hogan D.B., Patten S.B., Johnson J.A., Romonko-Slack L., Maxwell C.J. Medication nonadherence and subsequent risk of hospitalization and mortality among older adults. Drugs Aging 2006, 23(4):345-356.
117. Vinks T.H.A.M., Egberts T.C.G., de Lang T.M., de Koning F.H.P. Pharmacist-based medication review reduces potential drug related problems in elderly. Drugs Aging 2009, 26(2):123-133.
118. Wallsten S.M., Sullivan R.J., Hanlon J.T., Blazer D.G., Tyrey M.J., Westlund R. Medication taking behaviors in the high- and low-functioning elderly: MacArthur field studies of successful aging. Ann. Pharmacother. 1995, 29:359-364.
119. Wijk H., Berg S., Sivik L., Steen B. Colour discrimination, colour naming and colour preference among indivuduals with Alzheimer's Disease. Int. J. Geriat. Psychiatry 1999, 14:1000-1005.
120. Wijk H., Berg S., Berman B., Borjesson Hanson A., Sivik L., Steen B. Colour perception among the very elderly related to visual and cognitive functions. Scand. J. Caring Sci. 2002, 16:91-102.
121. Wijk H., Sivik L. Some aspects of colour perception among patients with Alzheimer's disease. Scand. J. Caring Sci. 1995, 9:3-9.
122. Wiley J.W. Aging and neural control of the GI tract III. Senescent enteric nervous system: lessons from extraintestinal sites and nonmammalian species. Am. J. Physiol. Gastrointest. Liver Physiol. 2002, 283:G1020-G1026.
123. Wilson E.A.H., Wolf M.S. Working memory and the design of health material: a cognitive factors perspective. Patient Educ. Counsel. 2009, 74:318-322.
124. Windham B.G., Griswold M.E., Fried L.P., Rubin G.S., Xue Q.-L., Carlson M.C. Impaired vision and the ability to take medications. J. Am. Geriatr. Soc. 2005, 53:1179-1190.
125. Woodward M. Hypnosedatives in the elderly-a guide to appropriate use. CNS Drugs 1999, 11(4):263-279.
126. Yamanake T., Takasugi E., Hotta N., Kubo Y., Otsuka K. Daily living functions of the elderly requiring home visits: a study at a comprehensive assessment clinic for the elderly. Geriatr. Gerontol. Int. 2007, 7:388-392.